Label: NU-DERM CLEAR SKIN BLEACHING AND CORRECTOR- hydroquinone cream
NU-DERM BLENDER SKIN LIGHTENER AND BLENDING- hydroquinone cream
NU-DERM SUNFADER SKIN LIGHTENER WITH SUNSCREEN (SPF 15) PABA FREE- hydroquinone, octinoxate, and oxybenzone lotion

  • NDC Code(s): 62032-100-10, 62032-100-36, 62032-101-36, 62032-116-36
  • Packager: Obagi Cosmeceuticals LLC
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated November 12, 2019

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    Rx Only

    For external use only

  • DESCRIPTION

    Hydroquinone is 1, 4-benzenediol. The drug is freely soluble in water and in alcohol. Chemically, hydroquinone is designed as p-dihydroxybenzene; the empirical formula is C6H6O2; molecular weight is 110.11 g/mol. The chemical structure is in the diagram below.

    Chemical Structure

    Each gram of Obagi Nu-Derm Clear contains:

    Active ingredient: Hydroquinone USP, 4% (40 mg/g)

    Inactive ingredients: water, cetyl alcohol, glycerin, sodium lauryl sulfate, stearyl alcohol, lactic acid, tocopheryl acetate, ascorbic acid, sodium metabisulfite, disodium EDTA, methylparaben, BHT, propylparaben, saponins, butylparaben

    Each gram of Obagi Nu-Derm Blender contains:

    Active ingredient: Hydroquinone USP, 4% (40 mg/g)

    Inactive ingredients: water, glycerin, cetyl alcohol, PPG-2 myristyl ether propionate, sodium lauryl sulfate, TEA-salicylate, lactic acid, phenyl trimethicone, tocopheryl acetate, sodium metabisulfite, ascorbic acid, methylparaben, disodium EDTA, propylparaben, saponins, BHT

    Each gram of Obagi Nu-Derm Sunfader contains:

    Active ingredients: Hydroquinone USP, 4% (40 mg/g); Octinoxate USP, 7.5%; Oxybenzone USP, 5.5%

    Inactive ingredients: water, cetyl alcohol, glycerin, sodium lauryl sulfate, stearyl alcohol, tocopheryl acetate, ascorbic acid, sodium metabisulfite, disodium EDTA, methylparaben, BHT, saponins, propylparaben, butylparaben

  • CLINICAL PHARMACOLOGY

    Topical application of hydroquinone produces a reversible depigmentation of the skin by inhibition of the enzymatic oxidation of tyrosine to 3, 4-dihydroxyphenylalanine (DOPA) and suppression of other melanocyte metabolic processes. Exposure to sunlight or ultraviolet light will cause repigmentation of the bleached areas, which may be prevented by the use of sunblocking agents or sunscreen agents contained in Obagi Nu-Derm Sunfader and Obagi Nu-Derm Sun Shield Matte Broad Spectrum SPF 50.

  • INDICATIONS AND USAGE

    For the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines, and other unwanted areas of melanin hyperpigmentation.

  • CONTRAINDICATIONS

    People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.

  • WARNINGS

    Hydroquinone is a skin-bleaching agent, which may produce unwanted cosmetic effects if not used as directed. The physician should be familiar with the contents of this insert before prescribing or dispensing this product.

    Test for skin sensitivity before using by applying a small amount to an unbroken patch of skin and check within 24 hours. Minor redness is not a contraindication, but where there is itching or vesicle formation or excessive inflammatory response, product should be discontinued and physician consulted. Close patient supervision is recommended.

    Warnings: Avoid contact with eyes, nose, mouth, and lips.In case of accidental contact, patient should rinse thoroughly with water and contact a physician. Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.

    Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.

  • PRECAUTIONS

    (Also see WARNINGS)

    Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.

    Pregnancy Category C

    Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.

    Nursing Mothers

    It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.

    Pediatric Usage

    Safety and effectiveness in children below the age of 12 years have not been established.

  • ADVERSE REACTIONS

    No systemic adverse reactions have been reported. Occasional hypersensitivity (localized contact dermatitis) may occur, in which case the product should be discontinued and the physician notified immediately.

  • DOSAGE AND ADMINISTRATION

    A thin application should be applied once or twice daily or as directed by a physician. If no improvement is seen after three (3) months of treatment, use of this product should be discontinued. Sun exposure should be limited by using a sunscreen agent, a sunblocking agent, or protective clothing to cover bleached skin when using and after using this product in order to prevent darkening from reoccurring.

  • HOW SUPPLIED

    Obagi Nu-Derm Clear is available as follows:

    Net wt. 2 oz. (57 g) bottle
    NDC 62032-101-36

    Obagi Nu-Derm Blender is available as follows:

    Net wt. 2 oz. (57 g) bottle
    NDC 62032-100-36

    Net wt. 1 oz. (28 g) bottle
    NDC 62032-100-10

    Obagi Nu-Derm Sunfader is available as follows:

    Net wt. 2 oz. (57 g) bottle
    NDC 62032-116-36

    Store at controlled room temperature: 15°C-25°C (59°F-77°F). Keep out of direct sunlight.

  • SPL UNCLASSIFIED SECTION

    ⍰ 1-800-636-7546

    Manufactured for:
    Obagi Cosmeceuticals LLC,
    Long Beach, CA 90806

    All products/brand names, whether designated by notice or not (®/TM), are trademarks of Obagi Cosmeceuticals LLC

    ©2018 Obagi Cosmeceuticals LLC.
    All rights reserved.
    www.obagi.com

    Revised 03/2018
    9458403

  • PRINCIPAL DISPLAY PANEL - 57 g Bottle Label - 3

    OBAGI

    NU-DERM®
    NDC 62032-101-36

    AM CLEAR
    PM
    3

    SKIN BLEACHING
    & CORRECTOR CREAM

    HYDROQUINONE USP, 4%
    Rx ONLY

    Net wt. 2 oz. (57g)

    PRINCIPAL DISPLAY PANEL - 57 g Bottle Label - 3
  • PRINCIPAL DISPLAY PANEL - 57 g Bottle Label - 5

    OBAGI

    NU-DERM®
    NDC 62032-100-36

    BLENDER®

    PM
    5

    SKIN LIGHTENER
    & BLENDING CREAM

    HYDROQUINONE USP, 4%
    Rx ONLY

    Net wt. 2 oz. (57g)

    PRINCIPAL DISPLAY PANEL - 57 g Bottle Label - 5
  • PRINCIPAL DISPLAY PANEL - 57 g Bottle Label - 6

    OBAGI

    NU-DERM®
    NDC 62032-116-36

    AM
    6

    SUNFADER®
    HYDROQUINONE USP, 4%

    SKIN LIGHTENER
    WITH SUNSCREEN
    (SPF 15) PABA-FREE

    Rx only

    Net wt. 2 oz. (57 g)

    PRINCIPAL DISPLAY PANEL - 57 g Bottle Label - 6
  • INGREDIENTS AND APPEARANCE
    NU-DERM CLEAR  SKIN BLEACHING AND CORRECTOR
    hydroquinone cream
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:62032-101
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    HYDROQUINONE (UNII: XV74C1N1AE) (HYDROQUINONE - UNII:XV74C1N1AE) HYDROQUINONE40 mg  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
    STEARYL ALCOHOL (UNII: 2KR89I4H1Y)  
    LACTIC ACID, UNSPECIFIED FORM (UNII: 33X04XA5AT)  
    .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    ASCORBIC ACID (UNII: PQ6CK8PD0R)  
    SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    BUTYLPARABEN (UNII: 3QPI1U3FV8)  
    Product Characteristics
    ColorWHITEScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:62032-101-3657 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product01/01/1988
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    Unapproved drug other01/01/1988
    NU-DERM BLENDER  SKIN LIGHTENER AND BLENDING
    hydroquinone cream
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:62032-100
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    HYDROQUINONE (UNII: XV74C1N1AE) (HYDROQUINONE - UNII:XV74C1N1AE) HYDROQUINONE40 mg  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    PPG-2 MYRISTYL ETHER PROPIONATE (UNII: 88R97D8U8A)  
    SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
    TROLAMINE SALICYLATE (UNII: H8O4040BHD)  
    LACTIC ACID, UNSPECIFIED FORM (UNII: 33X04XA5AT)  
    PHENYL TRIMETHICONE (UNII: DR0K5NOJ4R)  
    .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
    ASCORBIC ACID (UNII: PQ6CK8PD0R)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
    Product Characteristics
    ColorWHITEScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:62032-100-1028 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product01/01/1988
    2NDC:62032-100-3657 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product01/01/1988
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    Unapproved drug other01/01/1988
    NU-DERM SUNFADER  SKIN LIGHTENER WITH SUNSCREEN (SPF 15) PABA FREE
    hydroquinone, octinoxate, and oxybenzone lotion
    Product Information
    Product TypeHUMAN PRESCRIPTION DRUGItem Code (Source)NDC:62032-116
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    HYDROQUINONE (UNII: XV74C1N1AE) (HYDROQUINONE - UNII:XV74C1N1AE) HYDROQUINONE40 mg  in 1 g
    OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE75 mg  in 1 g
    OXYBENZONE (UNII: 95OOS7VE0Y) (OXYBENZONE - UNII:95OOS7VE0Y) OXYBENZONE55 mg  in 1 g
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    CETYL ALCOHOL (UNII: 936JST6JCN)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    SODIUM LAURYL SULFATE (UNII: 368GB5141J)  
    STEARYL ALCOHOL (UNII: 2KR89I4H1Y)  
    .ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)  
    ASCORBIC ACID (UNII: PQ6CK8PD0R)  
    SODIUM METABISULFITE (UNII: 4VON5FNS3C)  
    EDETATE DISODIUM (UNII: 7FLD91C86K)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    BUTYLPARABEN (UNII: 3QPI1U3FV8)  
    Product Characteristics
    ColorWHITEScore    
    ShapeSize
    FlavorImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:62032-116-3657 g in 1 BOTTLE, PLASTIC; Type 0: Not a Combination Product01/01/1984
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    Unapproved drug other01/01/1984
    Labeler - Obagi Cosmeceuticals LLC (790553353)
    Establishment
    NameAddressID/FEIBusiness Operations
    PureTek Corporation785961046MANUFACTURE(62032-101, 62032-100, 62032-116) , LABEL(62032-101, 62032-100, 62032-116) , PACK(62032-101, 62032-100, 62032-116)
    Establishment
    NameAddressID/FEIBusiness Operations
    G.S. COSMECEUTICAL USA, INC.017014734MANUFACTURE(62032-101, 62032-100)